Article
Metabolic medications modify prostate cancer progression through exosome reprogramming
2025-12-10
Abstract excerpt
Among prostate cancer patients, co-morbid Type 2 Diabetes (T2D) is associated with faster progression to biochemical recurrence and increased risk of mortality. Previous work from our lab provides evidence that exosomes purified from media of insulin resistant adipocytes or T2D patient plasma likely drives these outcomes by delivering miRNAs that exacerbate tumor aggressiveness in several breast and prostate cance...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f40ecb5-fb8d-5899-88c5-72dd93983d2d
- DOI
- 10.64898/2025.12.07.692844
